Astera Labs (NASDAQ:ALAB) Stock Price Down 1.8% – Should You Sell?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded down 1.8% during trading on Friday . The company traded as low as $329.61 and last traded at $343.05. 5,959,902 shares changed hands during trading, an increase of 7% from the average session volume of 5,547,847 shares. The stock had previously closed at $349.17.

Analyst Ratings Changes

A number of analysts have commented on the stock. UBS Group assumed coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective for the company. Roth Mkm reaffirmed a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. TD Cowen upped their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Finally, Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Price Performance

The business has a fifty day moving average of $186.48 and a 200 day moving average of $163.86. The stock has a market cap of $58.80 billion, a price-to-earnings ratio of 231.79, a P/E/G ratio of 4.31 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 28,737 shares of Astera Labs stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer directly owned 3,789,232 shares in the company, valued at $945,868,091.84. The trade was a 0.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares of the company’s stock, valued at $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 2,316,257 shares of company stock worth $474,860,636 over the last ninety days. 12.50% of the stock is currently owned by insiders.

Institutional Trading of Astera Labs

A number of institutional investors have recently added to or reduced their stakes in the business. Nordea Investment Management AB acquired a new stake in shares of Astera Labs in the fourth quarter worth $2,028,000. Geneva Partners LLC acquired a new stake in shares of Astera Labs in the third quarter worth $1,876,000. Numerai GP LLC grew its stake in shares of Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares during the last quarter. Swedbank AB grew its stake in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares during the last quarter. Finally, Handelsbanken Fonder AB grew its stake in shares of Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after acquiring an additional 93,800 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.